(PharmaNewsWire.Com, August 15, 2017 ) UTI is an infection occurred in any part of the urinary system. The infection mostly involves the lower part of the urinary tract. UTI can be classified into different types depending on the portion of the urinary system affected. Women are comparatively at a higher risk of developing UTI as compared with men since the urethra of the women is comparatively smaller than men and is also closer to the anus. This anatomical structure of the urinary tract in women increases the chances of transfer of the bacteria to the bladder. However, people of any sex and age can get affected by the disease.
Publisher's analysts forecast the global urinary tract infection treatment market to grow at a CAGR of 2.15% during the period 2017-2021. For more information about this report: http://www.reportsweb.com/global-urinary-tract-infection-treatment-market-2017-2021 . Covered in this report The report covers the present scenario and the growth prospects of the global urinary tract infection treatment market for 2017-2021. To calculate the market size, the report considers the sales of branded, off-label, and generic drugs.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Urinary Tract Infection Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
